China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study of multi-parameter MRI and contrast-enhanced ultrasound cognitive fusion based on PI-RADS v2.1 in guiding prostate targeted puncture in patients with PSA gray area.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132493
Registration Time: 2026/09/15
Type: Interventional study
Primary Sponsor: Meishan City Peoples Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=264463
Published by HT Digital Content Services with permission from Health Daily Digest....